AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BROLUCIZUMAB
9 registrations across 7 African markets— 9 active
Markets with BROLUCIZUMAB
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| VSIQQ | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jun 2031 |
| Pagenax Solution for injection 120 mg/ml Solution For Injection | 🇰🇪Kenya | Novartis Overseas Investments AG | active | Sept 2028 |
| Pagenax 120 mg/mL Solution for Injection** Solution for intravitreal injection | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Mar 2028 |
| PAGENAX SOLUTION; INJECTION | 🇿🇼Zimbabwe | NOVARTIS OVERSEAS INVESTMENTS AG | active | Mar 2028 |
| Pagenax Solution for injection | 🇹🇿Tanzania | NVS Kenya Limited | active | — |
| BROLUCIZUMAB PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | NVS KENYA LTD | active | — |
| PAGENAX® 120MG/ML SI I.VIT BTE(1FL + 1AIGUILLE) NOVARTIS Solution pour injection | 🇲🇬Madagascar | NOVARTIS PHARMA SERVICES | active | — |
| BROLUCIZUMAB PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | NVS KENYA LTD | active | — |
| PAGENAX® 120MG/ML SI I.VIT BTE(1FL + 1AIGUILLE) NOVARTIS Solution pour injection | 🇲🇬Madagascar | NOVARTIS PHARMA SERVICES | active | — |
BROLUCIZUMAB in Africa — Regulatory Overview
BROLUCIZUMAB is registered across 7 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Uganda, Kenya, South Africa and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.